Top Markets
#1 ADO Protocol ADO Protocol +337.07%
#2 GoPlus Security GoPlus Security +52.45%
#3 Starpower Starpower +36.27%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.77%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +20.07%
#7 Nockchain Nockchain +18.00%
#8 Fake World Assets Fake World Assets +17.14%
#9 DMT-NAT DMT-NAT +14.82%
#10 Casper Network Casper Network +11.97%
Coin of the day
ADO Protocol ADO Protocol
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Rang în acțiuni #33468
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Preț acțiune
$0.17580153
Capitalizare de piață
$7.59M
Schimbare (1 zi)
-0.13%
Schimbare (1 an)
-30.21%
Țară
IN
Tranzacționează Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Categorie

Healthcare
Venituri pentru Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Bharat Immunologicals & Biologicals Corporation Limited, venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Bharat Immunologicals & Biologicals Corporation Limited din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US